Single-step purification of full-length human androgen receptor
Nuclear Receptor Signaling · 2005
DOI: 10.1621/nrs.03001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Receptor Signaling, 2005. Verfasst von Dalia Juzumiene und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
The full-length human androgen receptor with an N-terminal biotin acceptor peptide tag was overexpressed in Spodoptera frugiperda cells in the presence of 1 μM dihydrotestosterone. Site-specific biotinylation of BAP was achieved in vivo by co-expression of E. coli biotin holoenzyme synthetase. The androgen receptor was purified by single-step affinity chromatography using Streptavidin Mutein Matrix under native conditions. The resultant protein was active, stable, 95% homogeneous, and we obtained sufficient yield for use in functional and structural studies.
Autor:innen und Institutionen
- Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Juzumiene, D., Chang, C. Y., Fan, D., Hartney, T., Norris, J. D., & McDonnell, D. P. (2005). Single-step purification of full-length human androgen receptor. Nuclear Receptor Signaling. https://doi.org/10.1621/nrs.03001
Vancouver
Juzumiene D, Chang CY, Fan D, Hartney T, Norris JD, McDonnell DP. Single-step purification of full-length human androgen receptor. Nuclear Receptor Signaling. 2005. doi:10.1621/nrs.03001
BibTeX
@article{Juzumiene2005,
author = {Juzumiene, Dalia and Chang, Ching-yi and Fan, Daju and Hartney, Tanya and Norris, John D and McDonnell, Donald P},
title = {Single-step purification of full-length human androgen receptor},
journal = {Nuclear Receptor Signaling},
year = {2005},
doi = {10.1621/nrs.03001}
}
EUVIMED